Free Trial

Shockwave Medical (SWAV) Stock Forecast & Price Target

Notice: This company has been marked as potentially delisted and may not be actively trading.

Shockwave Medical - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 11 Wall Street analysts who have issued ratings for Shockwave Medical in the last 12 months, the stock has a consensus rating of "Hold." Out of the 11 analysts, 10 have given a hold rating, and 1 has given a buy rating for SWAV.

Consensus Price Target

$309.11
-7.66% Downside
High Forecast$368.00
Average Forecast$309.11
Low Forecast$210.00

According to the 11 analysts' twelve-month price targets for Shockwave Medical, the average price target is $309.11. The highest price target for SWAV is $368.00, while the lowest price target for SWAV is $210.00. The average price target represents a forecasted downside of -7.66% from the current price of $334.75.

TypeCurrent Forecast
7/20/23 to 7/19/24
1 Month Ago
6/20/23 to 6/19/24
3 Months Ago
4/21/23 to 4/20/24
1 Year Ago
7/20/22 to 7/20/23
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
6 Buy rating(s)
Hold
10 Hold rating(s)
10 Hold rating(s)
10 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$309.11$309.11$309.11$281.50
Forecasted Upside-7.66% Downside4.24% Upside4.24% Upside15.06% Upside
Get Shockwave Medical Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SWAV and its competitors with MarketBeat's FREE daily newsletter.

SWAV Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SWAV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Shockwave Medical Stock vs. The Competition

TypeShockwave MedicalMedical CompaniesS&P 500
Consensus Rating Score
2.09
2.72
2.51
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside-7.66% Downside1,353.99% Upside9.10% Upside
News Sentiment RatingNeutral News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/8/2024SVB Leerink
1 of 5 stars
 Reiterated RatingOutperform ➝ Market Perform$361.00 ➝ $335.00+2.79%
4/8/2024CL King
2 of 5 stars
 Reiterated RatingBuy ➝ Neutral
4/8/2024Deutsche Bank Aktiengesellschaft
2 of 5 stars
 Reiterated RatingBuy ➝ Hold$270.00 ➝ $335.00+2.67%
4/8/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Equal Weight$285.00 ➝ $335.00+2.65%
4/5/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Kratky
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
4/5/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold$263.00 ➝ $335.00+2.51%
4/5/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold
4/5/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Peer Perform
4/2/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$290.00 ➝ $360.00+12.32%
2/16/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$200.00 ➝ $210.00-20.74%
9/29/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$218.00+6.11%
5/9/2023VNET Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
4/11/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$235.00 ➝ $275.00+21.20%
9/6/2022Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeMarket Perform ➝ Underperform$165.00-43.53%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 02:51 AM ET.

SWAV Forecast - Frequently Asked Questions

What is Shockwave Medical's forecast for 2024?

According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Shockwave Medical is $309.11, with a high forecast of $368.00 and a low forecast of $210.00.

Should I buy or sell Shockwave Medical stock right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last year. There are currently 10 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" SWAV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SWAV, but not buy additional shares or sell existing shares.

Does Shockwave Medical's stock price have much upside?

According to analysts, Shockwave Medical's stock has a predicted upside of 4.24% based on their 12-month stock forecasts.

Do Wall Street analysts like Shockwave Medical more than its competitors?

Analysts like Shockwave Medical less than other "medical" companies. The consensus rating for Shockwave Medical is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how SWAV compares to other companies.


This page (NASDAQ:SWAV) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners